This webinar explores how the NEED (Needs Examination, Evaluation, and Dissemination) framework can enhance Health Technology Assessment (HTA) of Rare Disease Therapies (RDTs) by offering a structured approach to understanding unmet needs in rare diseases.
Expert speakers include:
- Alessandra Blonda, KU Leuven (Belgium)
- Irena Cleemput, KCE (Belgium)
- François Houÿez, EURORDIS (France)
- Nicole Mittmann, Canada’s Drug Agency (Canada)
- Elena Nicod, RDIG Project Group 2 Perspective (Italy)
- Vinciane Pirard, Sanofi (Belgium)
The session is moderated by Veronica Lopez Gusset, HTAi Rare Diseases Interest Group.
This is a valuable opportunity to gain insights and contribute to the discussion on improving HTA of rare disease technologies.
Watch the clip below and then follow the button to view the entire webinar on-demand.